Estoppel in District Court Applies to Prior Art that Does Not Differ Substantively—and in a Manner Germane to Invalidity—from that Asserted in IPR

Aug 30, 2019

Reading Time : 2 min

On Defendants’ motion for reconsideration, the court clarified its prior ruling. As an initial matter, the court noted that the parties disagreed on how to distinguish invalidity grounds that could have been raised in an IPR petition with those not subject to IPR estoppel. The Federal Circuit, as the court explained, has not addressed this dispute, nor have district courts dealt with the specific question at issue: whether IPR estoppel can preclude a patent challenger from relying on a “known or used” invalidity ground that is related to the printed publications that were asserted before the Patent Trial and Appeal Board (PTAB). The court, nevertheless, considered how other district courts have determined when estoppel should apply to prior art products and systems.

In one instance, the Central District of California declined to extend estoppel to a physical machine when the machine disclosed features not included in the printed publication. Star Envirotech, Inc. v. Redline Detection, LLC, No. 8:12-cv-01861 (C.D. Cal. Jan. 29, 2015). That court considered the machine a “superior and separate” reference. In another instance, the Northern District of Illinois found that “the relevant inquiry [was] not whether the ground is redundant of a ground that was asserted but, rather, whether the ground reasonably could have been raised.”  Clearlamp, LLC v. LKQ Corp., No. 1:12-cv-02533 (N.D. Ill. Mar. 18, 2016). That court found the defendant was attempting to “cloak” the underlying datasheet of a product (i.e., a printed publication) as an invalidity ground based on the product itself.

The court here declined to adopt the “superior and separate reference” standard. As the court explained, this standard would likely extend the reach of IPR estoppel beyond its intended scope. And it ignores a commonly found practice in patent litigation: using one prior art reference to meet the same claim limitations in a number of different invalidity arguments. Instead, the court favored the analysis in Clearlamp, finding that there must be some substantive difference between the two invalidity grounds that is germane to the invalidity dispute at hand to avoid estoppel.

Practice Tip: A district court defendant that asserts a “known or used by others” invalidity theory should be prepared to articulate the substantive differences in the prior art from that asserted at the PTAB in order to avoid IPR estoppel. In doing so, defendants should focus on differences that are germane to invalidity.

Cal. Inst. of Tech. v. Broadcom Ltd., et al., No. 2:16-cv-03714 (C.D. Cal. Aug. 9, 2019).

Share This Insight

Previous Entries

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

IP Newsflash

April 9, 2026

In the April 1, 2026 edition of the Official Gazette, the U.S. Patent and Trademark Office announced a new procedural framework that permits patent owners to submit a limited, early response to a request for ex parte reexamination.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.